Recovery of Hearing with Amidotrizoate in Sudden Deafness

DOI

Bibliographic Information

Other Title
  • 難治性突発性難聴に対するウログラフィン<sup>®</sup>の効果の検討

Description

We treated 23 patients with sudden hearling loss by intravenous administration of amidotrizoate (60% Urografin) after conventional therapy. The patients were initially treated with prednisolone, Vitamine B12, stellate ganglion block, and hyperbaric oxygen. Conventional therapy led to a partial recovery of hearing acuity and vertigo in 26.1% of the patients. However, there was no change in symptoms in the other patients. Twenty milliliters of amidotrizoate was intravenously administered every day for a week. Following treatment with amidotrizoate, a complete, marked, and partial recovery of symptoms was observed in 4.3%, 17.4%, and 34.8% of the patients, respectively. However, 43.5% of the patients showed no change in symptoms. No side effects were observed following amidotrizoate therapy. We conclude that intravenous administration of amidotrizoate may recover hearing in patients with sudden deafness.

Journal

Details 詳細情報について

  • CRID
    1390282679436504960
  • NII Article ID
    130004239192
  • DOI
    10.11321/jjspc1994.5.4_491
  • ISSN
    18841791
    13404903
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top